283 related articles for article (PubMed ID: 17198225)
61. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
[TBL] [Abstract][Full Text] [Related]
62. [Diagnosis of cancer with magnetic resonance imaging (MRI)].
Takahashi M; Sakamoto Y; Kojima R; Wakamatsu J
Gan No Rinsho; 1988 Aug; 34(10):1237-46. PubMed ID: 3172483
[TBL] [Abstract][Full Text] [Related]
63. [Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field].
Matsusue E; Ogawa T
Brain Nerve; 2007 May; 59(5):479-85. PubMed ID: 17533973
[TBL] [Abstract][Full Text] [Related]
64. Novel contrast mechanisms at high field 1.
Börnert P; Bieri O; Scheffler K
Semin Musculoskelet Radiol; 2008 Sep; 12(3):253-65. PubMed ID: 18850505
[TBL] [Abstract][Full Text] [Related]
65. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
66. Use of contrast media in neuroimaging.
Essig M; Dinkel J; Gutierrez JE
Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):633-48. PubMed ID: 23088943
[TBL] [Abstract][Full Text] [Related]
67. Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology.
Atar E
Isr Med Assoc J; 2004 Jul; 6(7):412-4. PubMed ID: 15274532
[TBL] [Abstract][Full Text] [Related]
68. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
69. Ultrasound imaging and contrast agents: a safe alternative to MRI?
Wink MH; Wijkstra H; De La Rosette JJ; Grimbergen CA
Minim Invasive Ther Allied Technol; 2006; 15(2):93-100. PubMed ID: 16754192
[TBL] [Abstract][Full Text] [Related]
70. Contrast-enhanced fat-suppression neuroimaging.
Simon JH; Rubinstein D
Neuroimaging Clin N Am; 1994 Feb; 4(1):153-73. PubMed ID: 8130947
[TBL] [Abstract][Full Text] [Related]
71. Undifferentiated (embryonal) sarcoma of the liver (USL): MRI findings including dynamic gadolinium enhancement.
Psatha EA; Semelka RC; Fordham L; Firat Z; Woosley JT
Magn Reson Imaging; 2004 Jul; 22(6):897-900. PubMed ID: 15234460
[TBL] [Abstract][Full Text] [Related]
72. Physiologic and metabolic magnetic resonance imaging in gliomas.
Cao Y; Sundgren PC; Tsien CI; Chenevert TT; Junck L
J Clin Oncol; 2006 Mar; 24(8):1228-35. PubMed ID: 16525177
[TBL] [Abstract][Full Text] [Related]
73. Functional mapping of neural pathways in rodent brain in vivo using manganese-enhanced three-dimensional magnetic resonance imaging.
Watanabe T; Frahm J; Michaelis T
NMR Biomed; 2004 Dec; 17(8):554-68. PubMed ID: 15617054
[TBL] [Abstract][Full Text] [Related]
74. Brain MRI: tumor evaluation.
Young RJ; Knopp EA
J Magn Reson Imaging; 2006 Oct; 24(4):709-24. PubMed ID: 16958058
[TBL] [Abstract][Full Text] [Related]
75. Abdominal magnetic resonance imaging at 3 T: oncological applications.
Marin D; Husarik DB; Boll DT; Merkle EM
Top Magn Reson Imaging; 2010 Jun; 21(3):149-56. PubMed ID: 21847034
[TBL] [Abstract][Full Text] [Related]
76. Contrast agents for functional and cellular MRI of the kidney.
Grenier N; Pedersen M; Hauger O
Eur J Radiol; 2006 Dec; 60(3):341-52. PubMed ID: 16973326
[TBL] [Abstract][Full Text] [Related]
77. MRI of brain disease in veterinary patients part 1: Basic principles and congenital brain disorders.
Hecht S; Adams WH
Vet Clin North Am Small Anim Pract; 2010 Jan; 40(1):21-38. PubMed ID: 19942055
[TBL] [Abstract][Full Text] [Related]
78. Magnetic resonance imaging using gadolinium-based contrast agents.
Mitsumori LM; Bhargava P; Essig M; Maki JH
Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
[TBL] [Abstract][Full Text] [Related]
79. Magnetic resonance contrast agents. Physical basis of relaxation.
Sobol WT
Neuroimaging Clin N Am; 1994 Feb; 4(1):27-42. PubMed ID: 8130950
[TBL] [Abstract][Full Text] [Related]
80. MR contrast agents, the old and the new.
Bellin MF
Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
